PubMed

Unravelling the Immunotoxicity of Polycaprolactone Nanoparticles-Effects of Polymer Molecular Weight, Hydrolysis, and Blends.

PMID: 33050694 · 2020-10-13

S, a, n, d, r, a, , J, e, s, u, s, ;, , N, a, t, a, l, i, a, , B, e, r, n, a, r, d, i, ;, , J, e, s, s, i, c, a, , d, a, , S, i, l, v, a, ;, , M, a, r, i, a, n, a, , C, o, l, a, ç, o, ;, , J, o, ã, o, , P, a, n, ã, o, , C, o, s, t, a, ;, , P, e, d, r, o, , F, o, n, t, e, ;, , O, l, g, a, , B, o, r, g, e, s

ЖурналChemical research in toxicology

Год2020-10-13

PMID33050694

Аннотация

Poly-ε-caprolactone (PCL) is a biodegradable polyester that has FDA and CE approval as a medical device. Nonetheless, the lack of toxicity exhibited by the polymer cannot be extrapolated to its nanomaterial conformation. Despite PCL-based NPs being widely studied in the biomedical field for their advantages as controlled drug delivery systems, little data describe PCL NPs' toxicity, particularly immunotoxicity. This work assessed different PCL-based delivery systems intended for protein delivery

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.